Results 171 to 180 of about 5,927,341 (295)

Boundary‐Dependent Sleep–Wake Dysregulation in Idiopathic Hypersomnia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Idiopathic hypersomnia (IH) presents with excessive daytime sleepiness (EDS) despite apparently preserved nocturnal sleep, challenging traditional models of hypersomnolence based on sleep loss or fragmentation. We aimed to test the hypothesis that EDS in IH reflects excessive stabilization of the sleep state, consistent with ...
Samantha Mombelli, Karine Lacourse, Hélène Blais, Anne‐Sophie Deshaies‐Rugama, Cynthia Thompson, Alex Desautels, Jacques Montplaisir, Milan Nigam, Christophe Moderie, Boshra Khajehpiri, Catherine Duclos, Jean Marc Lina, Julie Carrier, Nadia Gosselin   +13 more
wiley   +1 more source

Deep reinforcement learning-based intrusion detection scheme for software-defined networking. [PDF]

Sci Rep
Kanimozhi R, Ramesh PS.
europepmc   +1 more source

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang, Linxi Cao, Xiaodong Chen, Siqi Tong, Qinghui Zhu, Jun Yang, Song Lin, Yong Cui   +7 more
wiley   +1 more source

Tunnel enabled programmable switches obfuscate network topology to defend against link flooding reconnaissance in software defined networking. [PDF]

Sci Rep
Li X, Lee J, Son J, Lee Y.
europepmc   +1 more source

Enhancing the Internet of Things with Knowledge-Driven Software-Defined Networking Technology: Future Perspectives. [PDF]

Sensors (Basel), 2020
Li Y, Su X, Ding AY, Lindgren A, Liu X, Prehofer C, Riekki J, Rahmani R, Tarkoma S, Hui P.   +9 more
europepmc   +1 more source

Software-defined optical networking applications enabled by programmable integrated photonics

[EN] Data center networks are experiencing unprecedented exponential growth, mostly driven by the continuous computing demands in machine learning and artificial intelligence algorithms.
Sánchez-Jácome, David, Torrijos-Morán, Luis, Xie, Zhenyun, Pérez-López, Daniel   +3 more
core   +1 more source

Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li, Zhi‐Xian Ye, Xuan‐Yu Chen, Liang‐Liang Qiu, Zhi‐li Chen, Yu‐Sen Qiu, Wei Lin, Ru‐Ying Yuan, Xin‐Tong Yu, Chun‐Yu Huang, Xin‐Yuan Chen, Min‐Ting Lin, Jian‐Ping Hu, Wan‐Jin Chen, Ning Wang, Shao‐Bo Yao, Shi‐Rui Gan, Ying Fu   +17 more
wiley   +1 more source

Rethinking max-min planning on energy-efficient software-defined networking for 5G networks. [PDF]

Sci Rep
Jiang D, Zhu B, Sun J, Wang Z, Lyu Z, Singh AK, Yuan Z.   +6 more
europepmc   +1 more source

PERANCANGAN VIRTUAL NETWORK MENGGUNAKAN FLOWVISOR DAN OPENFLOW SOFTWARE DEFINED NETWORKING DI BPPT

, 2014
PERANCANGAN VIRTUAL NETWORK MENGGUNAKAN FLOWVISOR DAN OPENFLOW SOFTWARE DEFINED NETWORKING DI BPPT
MICHAEL BENJULIAN, RIO, NUR FADILLAH, ADI, Gunar Setiadji, M.Eng., Tatang, AMBARWATI ROCHIMAH, LUSY   +3 more
core  

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Given the role of Myostatin (MSTN) in muscle homeostasis and its modulation by current spinal muscular atrophy (SMA) therapies, we investigated serum MSTN and, for the first time, its downstream effector Smad3 as candidate non‐invasive biomarkers in SMA patients undergoing disease‐modifying therapies (DMTs).
Giorgia Riolo, Claudia Dosi, Stefano Parravicini, Riccardo Zanin, Marta Cheli, Eleonora Giacopuzzi Grigoli, Amalia Canciello, Francesca Andreetta, Riccardo Masson, Silvia Bonanno, Stefania Marcuzzo, Lorenzo Maggi   +11 more
wiley   +1 more source